Incompatibilities: This medicinal product must not be mixed with other medicinal products.
Special precautions for disposal and other handling: Parenteral medicinal products such as Idarucizumab (Praxbind) should be inspected visually for particulate matter and discoloration prior to administration.
Idarucizumab (Praxbind) must not be mixed with other medicinal products. A pre-existing intravenous line may be used for administration of Idarucizumab (Praxbind). The line must be flushed with sodium chloride 9 mg/ml (0.9 %) solution for injection prior to and at the end of infusion. No other infusion should be administered in parallel via the same intravenous access.
Idarucizumab (Praxbind) is for single-use only and does not contain preservatives.
No incompatibilities between Idarucizumab (Praxbind) and polyvinyl chloride, polyethylene or polyurethane infusion sets or polypropylene syringes have been observed.
Other Services
Country
Account